Qisda Corporation (TPE:2352)
Taiwan
· Delayed Price · Currency is TWD 29.45
+0.30 (1.03%)
Apr 2, 2025, 1:35 PM CST
Qisda Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 201,666 | 203,595 | 239,837 | 225,961 | 191,702 | Upgrade
|
| Revenue Growth (YoY) | -0.95% | -15.11% | 6.14% | 17.87% | 12.93% | Upgrade
|
| Cost of Revenue | 168,485 | 170,519 | 205,276 | 193,404 | 164,875 | Upgrade
|
| Gross Profit | 33,181 | 33,076 | 34,561 | 32,557 | 26,827 | Upgrade
|
| Selling, General & Admin | 22,046 | 21,154 | 21,431 | 18,939 | 15,349 | Upgrade
|
| Research & Development | 6,651 | 6,944 | 7,192 | 6,260 | 4,921 | Upgrade
|
| Operating Expenses | 28,662 | 28,065 | 28,709 | 25,196 | 20,214 | Upgrade
|
| Operating Income | 4,520 | 5,011 | 5,852 | 7,361 | 6,613 | Upgrade
|
| Interest Expense | -1,851 | -1,808 | -1,197 | -688.56 | -758 | Upgrade
|
| Interest & Investment Income | 1,271 | 1,523 | 1,319 | 553.55 | 364.47 | Upgrade
|
| Earnings From Equity Investments | 178.55 | 405 | 366.57 | 1,608 | 499.57 | Upgrade
|
| Currency Exchange Gain (Loss) | 288.68 | 93.51 | 53.7 | -24.04 | -117.44 | Upgrade
|
| Other Non Operating Income (Expenses) | 273.92 | 373.14 | 398.9 | 735.11 | 927.02 | Upgrade
|
| EBT Excluding Unusual Items | 4,681 | 5,598 | 6,794 | 9,545 | 7,528 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -6.59 | Upgrade
|
| Gain (Loss) on Sale of Investments | -24.49 | -23.59 | 97.61 | 3,023 | 690.88 | Upgrade
|
| Gain (Loss) on Sale of Assets | -8.16 | 745.48 | 9,659 | 524.54 | -0.14 | Upgrade
|
| Asset Writedown | - | - | -7.7 | - | - | Upgrade
|
| Legal Settlements | - | - | - | -100.25 | - | Upgrade
|
| Other Unusual Items | - | - | 81.09 | 0.1 | - | Upgrade
|
| Pretax Income | 4,648 | 6,320 | 16,623 | 12,992 | 8,213 | Upgrade
|
| Income Tax Expense | 1,834 | 1,804 | 5,544 | 2,509 | 1,846 | Upgrade
|
| Earnings From Continuing Operations | 2,814 | 4,516 | 11,079 | 10,483 | 6,367 | Upgrade
|
| Minority Interest in Earnings | -650.25 | -1,540 | -2,827 | -2,175 | -1,378 | Upgrade
|
| Net Income | 2,164 | 2,976 | 8,252 | 8,308 | 4,988 | Upgrade
|
| Net Income to Common | 2,164 | 2,976 | 8,252 | 8,308 | 4,988 | Upgrade
|
| Net Income Growth | -27.28% | -63.94% | -0.67% | 66.53% | 39.54% | Upgrade
|
| Shares Outstanding (Basic) | 1,955 | 1,967 | 1,967 | 1,967 | 1,967 | Upgrade
|
| Shares Outstanding (Diluted) | 1,962 | 1,976 | 1,995 | 1,992 | 1,987 | Upgrade
|
| Shares Change (YoY) | -0.70% | -0.95% | 0.12% | 0.28% | 0.06% | Upgrade
|
| EPS (Basic) | 1.11 | 1.51 | 4.20 | 4.22 | 2.54 | Upgrade
|
| EPS (Diluted) | 1.10 | 1.51 | 4.14 | 4.17 | 2.51 | Upgrade
|
| EPS Growth | -27.15% | -63.53% | -0.72% | 66.14% | 39.44% | Upgrade
|
| Free Cash Flow | -2,217 | 8,563 | -7,729 | -3,985 | 9,846 | Upgrade
|
| Free Cash Flow Per Share | -1.13 | 4.33 | -3.88 | -2.00 | 4.96 | Upgrade
|
| Dividend Per Share | 1.110 | 1.200 | 2.000 | 2.500 | 1.500 | Upgrade
|
| Dividend Growth | -7.50% | -40.00% | -20.00% | 66.67% | 100.00% | Upgrade
|
| Gross Margin | 16.45% | 16.25% | 14.41% | 14.41% | 13.99% | Upgrade
|
| Operating Margin | 2.24% | 2.46% | 2.44% | 3.26% | 3.45% | Upgrade
|
| Profit Margin | 1.07% | 1.46% | 3.44% | 3.68% | 2.60% | Upgrade
|
| Free Cash Flow Margin | -1.10% | 4.21% | -3.22% | -1.76% | 5.14% | Upgrade
|
| EBITDA | 9,394 | 9,750 | 10,289 | 11,369 | 9,999 | Upgrade
|
| EBITDA Margin | 4.66% | 4.79% | 4.29% | 5.03% | 5.22% | Upgrade
|
| D&A For EBITDA | 4,875 | 4,739 | 4,437 | 4,008 | 3,386 | Upgrade
|
| EBIT | 4,520 | 5,011 | 5,852 | 7,361 | 6,613 | Upgrade
|
| EBIT Margin | 2.24% | 2.46% | 2.44% | 3.26% | 3.45% | Upgrade
|
| Effective Tax Rate | 39.46% | 28.54% | 33.35% | 19.31% | 22.48% | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.